Navigation Links
MCTP bought Genomatix NextGen Sequencing analysis stations
Date:3/26/2009

nd computational analysis to search the human genomes of patients for abnormalities. They comprehensively examine disease development from the foundations of genetic abnormality up through whole body systems, to gain a more integrated, complete insight into the origins of disease.

The Genomatix Mining Station is the first level analysis solution starting at the raw data from the sequencer, delivering ultra fast mapping, SNP detection, expression profiling and splice analysis. Copy number analysis, small RNA analysis and de-novo assembly are following shortly.Results seamlessly feed into second level analysis with the Genomatix Genome Analyzer which puts them into broad biological context, annotates, integrates and visualizes. Clustering, pattern detection, deep transcription factor analysis, phylogeny, correlation and meta-analysis, pathway and network mining are done by the GGA.


'/>"/>

Contact: Klaus May
may@genomatix.de
49-895-997-660
Genomatix Software GmbH
Source:Eurekalert

Page: 1 2

Related biology news :

1. NIA uses Genomatix in stem cell research, suggests novel transcription factors for stemness
2. Pfizer inks global license to Genomatix Software and databases
3. Genomatix joins Illumina-Connect program
4. Boehringer Ingelheim uses Genomatix Next Generation Sequencing data analysis systems
5. CRG buys Genomatix Next Generation Sequencing analysis solution
6. Genomatix gets patent for comparative genomics method
7. 454 Sequencing uncovers a genetic basis for different social behaviors in wasp
8. 454 Sequencing: Science paper describes a novel, highly efficient method of sequencing ancient DNA
9. UC Irvine receives $2.18M to explore nano advancements in DNA sequencing
10. Microarray sequence capture speeds large-scale resequencing of targeted genomic regions
11. New technique could dramatically lower costs of DNA sequencing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 2014  Aware, Inc. (NASDAQ: AWRE ), ... announced on June 26, 2014 that its Board of ... per share, or approximately $40 million in total.  The ... and a payment date of July 24, 2014.  The ... set an ex-dividend date for this special cash dividend. ...
(Date:7/10/2014)... , July 2, 2014 It is ... to announce the appointment of the world-renowned Thoracic and ... of Directors. Dr. Ginsburg, with over 34 ... NY Presbyterian Hospital and Good Samaritan Regional Medical Center. ... since the late 1980,s and is considered an expert ...
(Date:7/10/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/h7h8lq/gesture ... "Global Gesture Recognition & Touch-Less Sensing (2D, 3D, ... report to their offering ... & Touch-Less Sensing Market to Grow Exponentially. Touch-less ... but the companies were unable to leverage this ...
Breaking Biology News(10 mins):NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share 2Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors 2Global Gesture Recognition & Touch-Less Sensing (2D, 3D, Ultrasonic, IR, Capacitive) Market - Forecasts to 2020 2
... Barbara, Calif.) Coastal marine ecosystems are at risk worldwide ... UC Santa Barbara who have recently published a study in ... performed the first integrated analysis of all coastal areas of ... must address a litany of impacts from human activities, from ...
... publish The HUGO Journal in cooperation with the ... Genomic Medicine, The HUGO Journal has a new ... of HUGO will receive free access to the journal online ... The HUGO Journal will focus on discoveries ...
... PHILADELPHIAThe Academy of Natural Sciences announced today that its ... member of the prestigious Biodiversity Heritage Library. The BHL ... botanical libraries and research institutions worldwide dedicated to digitizing ... it and to make it more widely available. Scanning ...
Cached Biology News:New study ranks 'hotspots' of human impact on coastal areas 2Academy Library accepted to prestigious Biodiversity Heritage Library 2
(Date:7/10/2014)... July 10, 2014 Product and ... very low abundance and are often “lost in ... time-consuming. , Join presenters Dr. Rowel Tobias, Senior ... John Anders, Head of Quality at Nanotherapeutics, Inc., ... that can speed detection and quantitation while achieving ...
(Date:7/10/2014)... 10, 2014 Understanding the need for ... lines, and the gap that currently exists in this ... its industry-leading portfolio of validated ion channel and GPCR ... cell lines, as ion channels control many critical physiological ... activity creates the potential to treat a variety of ...
(Date:7/10/2014)... CA (PRWEB) July 10, 2014 Unraveling ... closer together. The Archer Family purchased a ... within DNA, but ended up with a lifetime of ... contained within the family members’ DNA genuinely brought the ... decided to search deeper into genetic history and prior ...
(Date:7/10/2014)... (PRWEB) July 10, 2014 OMICS Group’s ... techniques during 18-20 August, 2014 at Double Tree by ... the recent developments in Analytical & Bioanalytical research methods ... , Speaking on this occasion, Dr. Srinubabu Gedela, MD ... Acta conference is a remarkable one in bringing a ...
Breaking Biology Technology:Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 2Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 3Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 4Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 5A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4
... , , ... board , Call by over 18% ... Significant funding shortfall identified in the Progen merger proposal , ... , Late last week Progen Pharmaceuticals Limited (ASX: PGL) responded to the ...
... Diffusion Pharmaceuticals LLC, a clinical-stage drug development company ... announced the completion of a $2.9 million private ... overall growth and clinical programs for its lead ... In addition, David G. Kalergis, Chief Executive Officer ...
... BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX ) ... year ended December 31, 2008. Fourth Quarter 2008 Financial ... 2008, the Company reported collaborative and other research and ... for the three months ended December 31, 2007. ...
Cached Biology Technology:Cytopia and Other Progen Shareholders Maintain Call for Meeting 2Cytopia and Other Progen Shareholders Maintain Call for Meeting 3Cytopia and Other Progen Shareholders Maintain Call for Meeting 4Diffusion Pharmaceuticals Announces Completion of a $2.9 Million Private Placement and Company Presentations at Upcoming Industry Conferences in Geneva, Switzerland and Naples, Florida 2Diffusion Pharmaceuticals Announces Completion of a $2.9 Million Private Placement and Company Presentations at Upcoming Industry Conferences in Geneva, Switzerland and Naples, Florida 3BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update 2BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update 3BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update 4BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update 5BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update 6BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update 7BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update 8BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update 9
Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms....
Experion StdSens chips are the microfluidic chips used to perform standard-sensitivity RNA analysis (nanogram levels) with the Experion automated electrophoresis system. Each chip has the capacity to...
...
Experion HighSens chips are the microfluidic chips used to perform high-sensitivity RNA analysis (picogram levels) with the Experion automated electrophoresis system. Each chip has the capacity to ru...
Biology Products: